ANGLE

Global Aging And Liquid Biopsy Will Redefine Early Cancer Detection

AnalystHighTarget

Not Invested

Community Contributor

Published

15 Aug 25

AnalystHighTarget's Fair Value

UK£0.30

89.2% undervalued

11 Sep

UK£0.033

-70.5%

8.3%

-70.5%

8.3%

You can edit this narrative until Aug 15 9:19 PM. Then, changes will post as Updates.

Author's Valuation

UK£0.3

89.2% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

UK£0.3

89.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

82.84%

Medical Equipment revenue growth rate

0.40%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.35%

Calculation

UK£735.01k

Earnings '28

167.44x

PE Ratio '28

UK£123.07m

Market Cap '28

UK£123.07m

Market Cap '28

326.00m

No. shares '28

UK£0.38

Share Price '28

UK£0.38 Share Price '28

Discounted to 2025 @ 8.18% p.a.

UK£0.30

Fair Value '25